Teva's Biosimilar Boom Just Beginnings: Is It Time to Buy?
Teva is turning the corner with a growing biosimilars roster and improving margins. This article examines whether tev...
Knowing when to adjust investments for retirement is crucial. Stay ahead by learning the best times and strategies for optimal financial health.
16,299 articlesTeva is turning the corner with a growing biosimilars roster and improving margins. This article examines whether tev...
CEO confidence dropped to a negative outlook in Q2 2026, suggesting the economy may worsen over the next six months. ...
Netflix faces a shifting market environment even as its ad-supported push gains momentum. This piece weighs the buy, ...
In the latest quarter, many hedge funds bought stakes in RidgePoint Heavy Equipment, a niche rental firm. The move si...
Figma is showing early signs of revival after a volatile debut, with improving revenue growth and expanding enterpris...
A chip-focused fund jumps roughly 80% in 2026, signaling investors are seeking broader exposure to AI infrastructure ...
When the market opened on Wednesday, Jabil shares surged as investors digested stronger-than-expected Q3 results and ...
A decades‑long pause in U.S. nuclear construction has reshaped the investment landscape, rewarding a utility with a l...
When a high-profile ad flares into a public family moment, it isn’t just entertainment. It’s a lesson in brand risk, ...
Alphabet stock appears positioned to outpace the broader market in 2026 as AI leadership strengthens its cloud and se...
A veteran market analyst argues that military drones, not consumer EVs, may drive the next leap in battery technology...
Bezos pivots from ecommerce to the physical economy, aiming at a $70 trillion market that spans manufacturing, drug d...